AMBRX Trademark

Trademark Overview


On Monday, January 25, 2021, a trademark application was filed for AMBRX with the United States Patent and Trademark Office. The USPTO has given the AMBRX trademark a serial number of 90487621. The federal status of this trademark filing is REGISTERED as of Tuesday, August 30, 2022. This trademark is owned by Ambrx, Inc.. The AMBRX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Development of new technology for others in the field of protein engineering; scientific research; industrial research in the field of biotechnology, human and veterinary medicine, genetic engineering, protein design, drug design, genetic therapy and molecular biology; research in genetic, medical, pharmaceutical and chemistry fields; laboratory research in the fields of biotechnology, human and veterinary medicine, genetic engineering, protein design, drug design, genetic therapy, molecular biology; scientific research, namely, studies of technical projects in the field of biotechnology, human and veterinary medicine, genetic engineering, protein design, drug design, genetic therapy and molecular biology
ambrx

General Information


Serial Number90487621
Word MarkAMBRX
Filing DateMonday, January 25, 2021
Status700 - REGISTERED
Status DateTuesday, August 30, 2022
Registration Number6830313
Registration DateTuesday, August 30, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 14, 2022

Trademark Statements


Goods and ServicesDevelopment of new technology for others in the field of protein engineering; scientific research; industrial research in the field of biotechnology, human and veterinary medicine, genetic engineering, protein design, drug design, genetic therapy and molecular biology; research in genetic, medical, pharmaceutical and chemistry fields; laboratory research in the fields of biotechnology, human and veterinary medicine, genetic engineering, protein design, drug design, genetic therapy, molecular biology; scientific research, namely, studies of technical projects in the field of biotechnology, human and veterinary medicine, genetic engineering, protein design, drug design, genetic therapy and molecular biology

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, April 26, 2021
Primary Code042
First Use Anywhere DateTuesday, April 13, 2004
First Use In Commerce DateTuesday, April 13, 2004

Trademark Owner History


Party NameAmbrx, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037

Party NameAmbrx, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037

Party NameAmbrx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLa Jolla, CA 92037

Trademark Events


Event DateEvent Description
Monday, August 30, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 28, 2021NEW APPLICATION ENTERED
Monday, April 26, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 10, 2021ASSIGNED TO EXAMINER
Tuesday, September 14, 2021WITHDRAWN FROM PUB - OG REVIEW QUERY
Friday, October 29, 2021PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, November 12, 2021NON-FINAL ACTION WRITTEN
Friday, November 12, 2021NON-FINAL ACTION E-MAILED
Friday, November 12, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, May 9, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, May 9, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 10, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 10, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 25, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 14, 2022PUBLISHED FOR OPPOSITION
Tuesday, June 14, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 30, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, August 30, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, May 15, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 15, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 15, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, May 15, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, May 15, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED